Galderma

galderma.com · Zug, Switzerland

Galderma is a global dermatology company that develops, manufactures, and markets prescription medicines, aesthetic injectables, and consumer skincare products for conditions such as acne, rosacea, psoriasis, and skin aging. It serves dermatologists, aesthetic practitioners, healthcare providers, and retail consumers through a portfolio that includes branded prescription therapies, injectable fillers and neuromodulators, and over‑the‑counter skincare lines. The company generates revenue by selling these products worldwide via medical, pharmacy, and retail distribution channels.

Revenue
$1B+
Employees
5,001+
Founded
1981
Headquarters
Zug, Switzerland

Galderma customers on Arbolus

Total customers 6 5 current · 1 former
Reviews growth 3 new reviews since Feb 2026

Customers who reviewed Galderma

Seniority of Galderma customers

Most people who reviewed Galderma hold C-Suite roles (67%), followed by Manager (17%) and Director (17%).

  • C-Suite 67%
  • Manager 17%
  • Director 17%

Customers sample

Marketing Leader Manager NPS 8 Undecided
Operations Generalist C-Suite NPS 8
Other Leader C-Suite NPS 10 Will renew

Employer names and spend open once the report publishes.

What 6 Arbolus experts think of Galderma

Overall sentiment: Positive

NPS distribution is heavily positive: 40% of responses are NPS 10, and 40% NPS 8–9. 60% of respondents indicate clear renewal intent, with only one negative response and one unsure. Implementation stage data confirms 100% of respondents have used Galderma solutions for more than a year, underscoring entrenched adoption. The key sentiment theme is high user satisfaction and strong product loyalty, particularly among end users.

Tell us when the Galderma report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

50 Net Promoter Score, from 6 scored reviews
  • Promoters 3
  • Passives 3
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 50%
  • Will renew 2
  • Undecided 1
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 67% 3 answers
  • Manager 0% 1 answer
  • 9.5/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers
  • 8/10 Average score from customers not renewing

For people who use Galderma

Do you use Galderma at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 6 customers of Galderma have already contributed

Takes a few minutes. Your identity stays anonymous.